Dame Emma Walmsley, the outgoing boss of the pharma giant, says she will miss the moment she gets the long-awaited results of her clinical trials
Jon Yeomans is the Deputy Business Editor at The Sunday Times. He specializes in corporate finance, corporations, entrepreneurship, and startups, providing insightful analysis and coverage of the dynamic business landscape. Jon's work has also been featured in The Australian, The Press, and The Times.












